[go: up one dir, main page]

WO2008021463A3 - Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders - Google Patents

Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders Download PDF

Info

Publication number
WO2008021463A3
WO2008021463A3 PCT/US2007/018201 US2007018201W WO2008021463A3 WO 2008021463 A3 WO2008021463 A3 WO 2008021463A3 US 2007018201 W US2007018201 W US 2007018201W WO 2008021463 A3 WO2008021463 A3 WO 2008021463A3
Authority
WO
WIPO (PCT)
Prior art keywords
analogs
methods
cycloheptene
treatment
amino substituted
Prior art date
Application number
PCT/US2007/018201
Other languages
French (fr)
Other versions
WO2008021463A2 (en
Inventor
Fredrik Ek
Roger Olsson
Jorgen Ohlsson
Original Assignee
Acadia Pharm Inc
Fredrik Ek
Roger Olsson
Jorgen Ohlsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acadia Pharm Inc, Fredrik Ek, Roger Olsson, Jorgen Ohlsson filed Critical Acadia Pharm Inc
Publication of WO2008021463A2 publication Critical patent/WO2008021463A2/en
Publication of WO2008021463A3 publication Critical patent/WO2008021463A3/en
Priority to US12/370,560 priority Critical patent/US20090239840A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed herein are analogs of clozapine and pharmaceutically acceptable salts, esters, amides, or prodrugs thereof; methods of synthesizing the analogs; and methods of using the analogs for treating neuorpsychiatric disorders. In some embodiments, the analogs are amino substituted diaryl[a,d]cycloheptenes.
PCT/US2007/018201 2003-12-22 2007-08-15 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders WO2008021463A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/370,560 US20090239840A1 (en) 2003-12-22 2009-02-12 AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83805606P 2006-08-15 2006-08-15
US60/838,056 2006-08-15

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/019,555 Continuation US7550454B2 (en) 2003-12-22 2004-12-21 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

Publications (2)

Publication Number Publication Date
WO2008021463A2 WO2008021463A2 (en) 2008-02-21
WO2008021463A3 true WO2008021463A3 (en) 2008-12-24

Family

ID=38819733

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/018201 WO2008021463A2 (en) 2003-12-22 2007-08-15 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

Country Status (1)

Country Link
WO (1) WO2008021463A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0922224A2 (en) 2008-12-08 2016-08-02 Vm Pharma Llc receptor protein tyrosine kinase inhibitor compositions.
US8999992B2 (en) 2013-03-15 2015-04-07 Vm Pharma Llc Crystalline forms of tryosine kinase inhibitors and their salts
ES2754385T3 (en) 2013-04-23 2020-04-17 Esteve Pharmaceuticals Sa Pyrazine- [1,2-a] indole compounds, their preparation and use in medicinal products
RU2610169C2 (en) 2014-09-11 2017-02-08 Общество С Ограниченной Ответственностью "Валентек" Derivatives of 7-fluoro-8-chloro-5h-dibenzo [b, e] [1, 4] diazepine and their application
JP2017529356A (en) 2014-09-17 2017-10-05 ムンディファーマ インターナショナル コーポレイション リミテッド Crystal forms of tyrosine kinase inhibitors and salts thereof
WO2018139471A1 (en) * 2017-01-25 2018-08-02 大日本住友製薬株式会社 Dibenzodiazepine derivative
CN107903244B (en) * 2017-11-29 2019-06-14 武汉珈创生物技术股份有限公司 2- amido with anti-tumor activity replaces Benzodiazepine compound and preparation method thereof
CN108586364B (en) * 2017-12-28 2021-11-09 新乡医学院 Dibenzoazepine compound and preparation method and application thereof
JP2021104931A (en) * 2018-02-22 2021-07-26 大日本住友製薬株式会社 Dibenzoazepine derivative having nitrogen-containing heterocycle
BR112022007503A2 (en) 2019-10-21 2022-07-12 Alairion Inc 3-(4-(11H-DIBENZO[B,E][1,4]AZEPIN-6-IL)PIPERAZIN-1-IL)-E 3-(4-(11H-DIBENZO[B,F] ACID DERIVATIVES [1,4]OXAZEPIN/TIAZEPIN/DIAZEPIN-11-IL)PIPERAZIN-1-IL)-PROPANOIC AS H1 AND 5-HT2A RECEPTOR MODULATORS FOR THE TREATMENT OF SLEEP DISORDERS

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH493538A (en) * 1966-12-16 1970-07-15 American Cyanamid Co 11-aminodibenz b f 1 4-oxa-thia-or dia-zepines
US3546226A (en) * 1963-03-01 1970-12-08 A Wander Sa Dr 11-basic-substituted dibenzoxazepines
FR2222102A1 (en) * 1973-03-23 1974-10-18 Wander Ag Dr A 11-Piperazino dibenzo diazepines neuroleptics - and anti-depressants, prepd. from a dibenzo diazepin-11-one and a piperazine
WO2005002586A1 (en) * 2003-07-02 2005-01-13 Astrazeneca Ab Metabolite of quetiapine
WO2005063254A2 (en) * 2003-12-22 2005-07-14 Acadia Pharmaceuticals Inc. Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
WO2006107948A2 (en) * 2005-04-04 2006-10-12 Acadia Pharmaceuticals Inc. Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents
WO2007062337A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Crystalline forms
WO2007062339A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Liquid formulations
WO2007062338A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Solid formulations
WO2007062336A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Salt forms
WO2008066620A2 (en) * 2006-10-20 2008-06-05 Concert Pharmaceuticals Inc. Dibenzothiazepine derivatives

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546226A (en) * 1963-03-01 1970-12-08 A Wander Sa Dr 11-basic-substituted dibenzoxazepines
CH493538A (en) * 1966-12-16 1970-07-15 American Cyanamid Co 11-aminodibenz b f 1 4-oxa-thia-or dia-zepines
FR2222102A1 (en) * 1973-03-23 1974-10-18 Wander Ag Dr A 11-Piperazino dibenzo diazepines neuroleptics - and anti-depressants, prepd. from a dibenzo diazepin-11-one and a piperazine
WO2005002586A1 (en) * 2003-07-02 2005-01-13 Astrazeneca Ab Metabolite of quetiapine
WO2005063254A2 (en) * 2003-12-22 2005-07-14 Acadia Pharmaceuticals Inc. Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
WO2006107948A2 (en) * 2005-04-04 2006-10-12 Acadia Pharmaceuticals Inc. Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents
WO2007062337A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Crystalline forms
WO2007062339A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Liquid formulations
WO2007062338A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Solid formulations
WO2007062336A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Salt forms
WO2008066620A2 (en) * 2006-10-20 2008-06-05 Concert Pharmaceuticals Inc. Dibenzothiazepine derivatives

Also Published As

Publication number Publication date
WO2008021463A2 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
WO2005063254A3 (en) Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
WO2008021463A3 (en) Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
WO2008044243A3 (en) Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
IL195178A0 (en) 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
IL195177A0 (en) 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
IL195176A0 (en) 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments
SI1589005T1 (en) Process for the synthesis of Ivabradine and its pharmaceutically acceptable acid addition salts
SI2024341T1 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
WO2008062276A3 (en) Acetylene derivatives as stearoyl coa desaturase inhibitors
PL1993985T3 (en) Process for the preparation of 1,2-propanediol
NZ594738A (en) Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same
ZA200805839B (en) Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of Alzheimer's disease via GABA receptors
SI2234979T1 (en) 5-((3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino)-1H-quinolin-2-ones, process for their production and their use as anti-inflammatory agents
WO2009061374A3 (en) Deuterated fingolimod
WO2007109288A3 (en) Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use
WO2010044585A3 (en) Piperidine compounds, pharmaceutical composition comprising the same and its use
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
IL180311A0 (en) Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters
WO2007126898A3 (en) Use of ladostigil for the treatment of schizophrenia
WO2007144699A3 (en) Process for the preparation of alfuzosin
WO2006136454A3 (en) Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease
WO2007110765A3 (en) Processes for the preparation of octreotide
ZA200501468B (en) Process for the synthesis of 1,3,4,5-tetrahydro-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
FR2915900B1 (en) NEW PROCESS FOR THE PREPARATION OF PURIFIED EXTRACTS OF HARPAGOPHYTUM PROCUMBENS.
PL2010538T3 (en) PROCESS FOR THE PREPARATION OF Ý(1R), 2S¨-2-AMINOPROPIONIC ACID 2-Ý4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLOÝ2,1-f¨Ý1,2,4¨TRIAZIN-6-YLOXY¨-1-METHYLETHYL ESTER

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07836943

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07836943

Country of ref document: EP

Kind code of ref document: A2